Clovis Oncology, Inc.
SEC CIK 1466301 · CLVS · last insider filing 2022-11-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mahaffy Patrick J | Director · See Remarks | filed 2011 - 2022 |
| Simantov Ronit | Director | filed 2021 - 2021 |
| Blair James C | Director | filed 2011 - 2021 |
| Graham Ginger L | Director | filed 2013 - 2021 |
| Atwood Brian G | Director | filed 2011 - 2021 |
| Spickschen Thorlef | Director | filed 2011 - 2021 |
| Mckinley Edward J | Director | filed 2011 - 2021 |
| Flaherty Keith T. | Director | filed 2013 - 2021 |
| Azelby Robert | Director | filed 2018 - 2021 |
| Fair Richard A. | Director | filed 2018 - 2021 |
| Klingenstein Paul H | Director | filed 2012 - 2021 |
| Barrett M James | Director | filed 2011 - 2018 |
| Reed John C | Director | filed 2011 - 2012 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Ivers-Read Gillian C | See Remarks | filed 2011 - 2022 |
| Muehl Daniel W | See remarks | filed 2016 - 2022 |
| Rolfe Lindsey | See remarks | filed 2015 - 2022 |
| Gross Paul Edward | See Remarks | filed 2019 - 2022 |
| Harding Thomas C. | See Remarks | filed 2020 - 2022 |
| Hooks Corwin Dale | See remarks | filed 2016 - 2018 |
| Mast Erle T | Executive VP and CFO | filed 2011 - 2015 |
| Hoerter Steven L. | See Remarks | filed 2011 - 2015 |
| Allen Andrew R | See Remarks | filed 2011 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.